Hormone Research in Paediatrics is growing. The attractiveness of the journal is steadily increasing, as shown by the number of submissions, the quality of articles and the established worldwide reputation as the leader journal in the field of pediatric endocrinology. Nevertheless, our constant commitment is to improve our journal further. In 2016, we are starting two new sections: ‘Translational Pediatric Endocrinology' and ‘Brief Reports'. ‘Translational Pediatric Endocrinology' is aimed at attracting translational research based on experimental studies in cells or animal models that can have a potential impact on the management of children with endocrine diseases, if confirmed in human beings. The ‘Brief Reports' section is aimed at attracting papers reporting preliminary research data and pilot studies. These two sections represent a further step forward in covering all aspects of pediatric endocrinology from bench to bedside and back again. Hoping these changes will be welcome by all of you, I take this opportunity to wish you a happy 2016 and an enjoyable and fruitful reading.

Stefano Cianfarani, Rome

Editor-in-Chief

Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.